These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 17942819)

  • 21. An apolipoprotein E-based therapeutic improves outcome and reduces Alzheimer's disease pathology following closed head injury: evidence of pharmacogenomic interaction.
    Wang H; Durham L; Dawson H; Song P; Warner DS; Sullivan PM; Vitek MP; Laskowitz DT
    Neuroscience; 2007 Feb; 144(4):1324-33. PubMed ID: 17187933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.
    Craft S; Baker LD; Montine TJ; Minoshima S; Watson GS; Claxton A; Arbuckle M; Callaghan M; Tsai E; Plymate SR; Green PS; Leverenz J; Cross D; Gerton B
    Arch Neurol; 2012 Jan; 69(1):29-38. PubMed ID: 21911655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial.
    Ritchie CW; Bush AI; Mackinnon A; Macfarlane S; Mastwyk M; MacGregor L; Kiers L; Cherny R; Li QX; Tammer A; Carrington D; Mavros C; Volitakis I; Xilinas M; Ames D; Davis S; Beyreuther K; Tanzi RE; Masters CL
    Arch Neurol; 2003 Dec; 60(12):1685-91. PubMed ID: 14676042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No effect of single-dose intranasal insulin treatment on verbal memory and sustained attention in patients with schizophrenia.
    Fan X; Copeland PM; Liu EY; Chiang E; Freudenreich O; Goff DC; Henderson DC
    J Clin Psychopharmacol; 2011 Apr; 31(2):231-4. PubMed ID: 21346605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CSF biomarkers in relationship to cognitive profiles in Alzheimer disease.
    van der Vlies AE; Verwey NA; Bouwman FH; Blankenstein MA; Klein M; Scheltens P; van der Flier WM
    Neurology; 2009 Mar; 72(12):1056-61. PubMed ID: 19307538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Facial emotion recognition deficit in amnestic mild cognitive impairment and Alzheimer disease.
    Spoletini I; Marra C; Di Iulio F; Gianni W; Sancesario G; Giubilei F; Trequattrini A; Bria P; Caltagirone C; Spalletta G
    Am J Geriatr Psychiatry; 2008 May; 16(5):389-98. PubMed ID: 18403572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study.
    Hampel H; Ewers M; Bürger K; Annas P; Mörtberg A; Bogstedt A; Frölich L; Schröder J; Schönknecht P; Riepe MW; Kraft I; Gasser T; Leyhe T; Möller HJ; Kurz A; Basun H
    J Clin Psychiatry; 2009 Jun; 70(6):922-31. PubMed ID: 19573486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Episodic memory and speed/attention deficits are associated with Alzheimer-typical CSF abnormalities in MCI.
    Nordlund A; Rolstad S; Klang O; Lind K; Pedersen M; Blennow K; Edman A; Hansen S; Wallin A
    J Int Neuropsychol Soc; 2008 Jul; 14(4):582-90. PubMed ID: 18577287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma lipoprotein beta-amyloid in subjects with Alzheimer's disease or mild cognitive impairment.
    Mamo JC; Jian L; James AP; Flicker L; Esselmann H; Wiltfang J
    Ann Clin Biochem; 2008 Jul; 45(Pt 4):395-403. PubMed ID: 18583625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial.
    Craft S; Claxton A; Baker LD; Hanson AJ; Cholerton B; Trittschuh EH; Dahl D; Caulder E; Neth B; Montine TJ; Jung Y; Maldjian J; Whitlow C; Friedman S
    J Alzheimers Dis; 2017; 57(4):1325-1334. PubMed ID: 28372335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective effect of rhubarb derivatives on amyloid beta (1-42) peptide-induced apoptosis in IMR-32 cells: a case of nutrigenomic.
    Misiti F; Sampaolese B; Mezzogori D; Orsini F; Pezzotti M; Giardina B; Clementi ME
    Brain Res Bull; 2006 Dec; 71(1-3):29-36. PubMed ID: 17113925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence of increased oxidative damage in subjects with mild cognitive impairment.
    Keller JN; Schmitt FA; Scheff SW; Ding Q; Chen Q; Butterfield DA; Markesbery WR
    Neurology; 2005 Apr; 64(7):1152-6. PubMed ID: 15824339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma beta amyloid and cytokine profile in women with Alzheimer's disease.
    Baranowska-Bik A; Bik W; Wolinska-Witort E; Martynska L; Chmielowska M; Barcikowska M; Baranowska B
    Neuro Endocrinol Lett; 2008 Feb; 29(1):75-9. PubMed ID: 18283248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice.
    Dall'Igna OP; Fett P; Gomes MW; Souza DO; Cunha RA; Lara DR
    Exp Neurol; 2007 Jan; 203(1):241-5. PubMed ID: 17007839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.
    Boissonneault V; Filali M; Lessard M; Relton J; Wong G; Rivest S
    Brain; 2009 Apr; 132(Pt 4):1078-92. PubMed ID: 19151372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trial.
    Sevigny JJ; Ryan JM; van Dyck CH; Peng Y; Lines CR; Nessly ML;
    Neurology; 2008 Nov; 71(21):1702-8. PubMed ID: 19015485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma amyloid beta42 and amyloid beta40 levels are associated with early cognitive dysfunction after cardiac surgery.
    Evered LA; Silbert BS; Scott DA; Maruff P; Laughton KM; Volitakis I; Cowie T; Cherny RA; Masters CL; Li QX
    Ann Thorac Surg; 2009 Nov; 88(5):1426-32. PubMed ID: 19853085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intranasal insulin improves memory in humans.
    Benedict C; Hallschmid M; Hatke A; Schultes B; Fehm HL; Born J; Kern W
    Psychoneuroendocrinology; 2004 Nov; 29(10):1326-34. PubMed ID: 15288712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effect of Z-ligustilide against amyloid beta-induced neurotoxicity is associated with decreased pro-inflammatory markers in rat brains.
    Kuang X; Du JR; Chen YS; Wang J; Wang YN
    Pharmacol Biochem Behav; 2009 Jun; 92(4):635-41. PubMed ID: 19324070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.